174 related articles for article (PubMed ID: 8164015)
1. Oral sumatriptan compared with placebo in the acute treatment of migraine.
Nappi G; Sicuteri F; Byrne M; Roncolato M; Zerbini O
J Neurol; 1994 Jan; 241(3):138-44. PubMed ID: 8164015
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results].
Centonze V; Polito MB; Di Bari M; Fabbri L; Cassiano MA; Bassi A; Albano O
Clin Ter; 1995 Nov; 146(11):721-8. PubMed ID: 8720348
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group.
Eur Neurol; 1991; 31(5):306-13. PubMed ID: 1653138
[TBL] [Abstract][Full Text] [Related]
4. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
5. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
6. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
7. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study.
Akpunonu BE; Mutgi AB; Federman DJ; Volinsky FG; Brickman K; Davis RL; Gilbert C; Asgharnejad M
Ann Emerg Med; 1995 Apr; 25(4):464-9. PubMed ID: 7710149
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
10. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA
Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310
[TBL] [Abstract][Full Text] [Related]
12. Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice.
Scott RJ; Aitchison WR; Barker PR; McLaren GI
QJM; 1996 Aug; 89(8):613-22. PubMed ID: 8935482
[TBL] [Abstract][Full Text] [Related]
13. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
14. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE
JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970
[TBL] [Abstract][Full Text] [Related]
15. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
[TBL] [Abstract][Full Text] [Related]
16. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group.
Eur Neurol; 1992; 32(3):177-84. PubMed ID: 1317294
[TBL] [Abstract][Full Text] [Related]
17. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths.
Cutler N; Mushet GR; Davis R; Clements B; Whitcher L
Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.
Tepper SJ; Cochran A; Hobbs S; Woessner M
Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565
[TBL] [Abstract][Full Text] [Related]
19. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
[TBL] [Abstract][Full Text] [Related]
20. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.
Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ
Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
